ATE278384T1 - Zusammensetzung, insbensodere für kosmetika, enthaltend dhea und/oder einen chemische oder biologische vorläufer davon und einen metalloproteinase inhibitor - Google Patents

Zusammensetzung, insbensodere für kosmetika, enthaltend dhea und/oder einen chemische oder biologische vorläufer davon und einen metalloproteinase inhibitor

Info

Publication number
ATE278384T1
ATE278384T1 AT01943592T AT01943592T ATE278384T1 AT E278384 T1 ATE278384 T1 AT E278384T1 AT 01943592 T AT01943592 T AT 01943592T AT 01943592 T AT01943592 T AT 01943592T AT E278384 T1 ATE278384 T1 AT E278384T1
Authority
AT
Austria
Prior art keywords
composition
chemical
cosmetics
metalloproteinase inhibitor
biological precursor
Prior art date
Application number
AT01943592T
Other languages
English (en)
Inventor
Lionel Breton
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE278384T1 publication Critical patent/ATE278384T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
AT01943592T 2000-07-13 2001-06-08 Zusammensetzung, insbensodere für kosmetika, enthaltend dhea und/oder einen chemische oder biologische vorläufer davon und einen metalloproteinase inhibitor ATE278384T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009218A FR2811561B1 (fr) 2000-07-13 2000-07-13 Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
PCT/FR2001/001788 WO2002005775A1 (fr) 2000-07-13 2001-06-08 Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase

Publications (1)

Publication Number Publication Date
ATE278384T1 true ATE278384T1 (de) 2004-10-15

Family

ID=8852482

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01943592T ATE278384T1 (de) 2000-07-13 2001-06-08 Zusammensetzung, insbensodere für kosmetika, enthaltend dhea und/oder einen chemische oder biologische vorläufer davon und einen metalloproteinase inhibitor

Country Status (8)

Country Link
US (1) US20040005370A1 (de)
EP (1) EP1303251B1 (de)
AT (1) ATE278384T1 (de)
AU (1) AU2001266133A1 (de)
DE (1) DE60106265T2 (de)
ES (1) ES2230329T3 (de)
FR (1) FR2811561B1 (de)
WO (1) WO2002005775A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811563B1 (fr) * 2000-07-13 2003-06-20 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive, et au moins un compose augmentant la synthese des glycosaminoglycanes
US7008929B2 (en) * 2002-04-02 2006-03-07 L'oreal Sapogenin-based treatment
FR2837704B1 (fr) * 2002-04-02 2005-01-14 Oreal Utilisation d'une sapogenine, ou un extrait naturel en contenant, pour le traitement des peaux seches oligoseborrheiques
US7354956B2 (en) * 2002-04-12 2008-04-08 L'oreal Composition containing a sapogenin and use thereof
FR2838344B1 (fr) * 2002-04-12 2005-06-17 Oreal Utilisation d'une sapogenine, ou d'un extrait naturel contenant, pour lisser les rides et ridules d'expression
FR2859908A1 (fr) * 2003-09-24 2005-03-25 Oreal Composition comprenant au moins un inhibiteur de metalloproteinase et au moins un agent myorelaxant ou relaxant
US20060252738A1 (en) * 2005-05-06 2006-11-09 Phero Tech Inc. Method for preparing and using water-based steroid pheromone compositions
JP5368793B2 (ja) 2005-07-18 2013-12-18 ユニバーシティ オブ マサチューセッツ ロウエル ナノエマルジョンを製造および使用するための組成物および方法
PT3144013T (pt) 2005-12-01 2019-02-07 Univ Massachusetts Lowell Nanoemulsões botulínicas
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
AU2007353340A1 (en) 2006-12-01 2008-11-20 Anterios, Inc. Peptide nanoparticles and uses therefor
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
CA2688415C (en) 2007-05-31 2015-11-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
US20090162306A1 (en) * 2007-12-21 2009-06-25 Conopco, Inc., D/B/A Unilever Topical composition comprising coloring antioxidants
JP2010535758A (ja) * 2008-01-04 2010-11-25 ビオスペクトルム，インコーポレイテッド ジオスゲニンを含む皮膚美白用組成物
US20110212157A1 (en) * 2008-06-26 2011-09-01 Anterios, Inc. Dermal delivery
JP2012500231A (ja) * 2008-08-18 2012-01-05 復旦大学附属中山医院 セラミド産生促進剤
CN105078810A (zh) * 2014-05-23 2015-11-25 广州市白云联佳精细化工厂 一种能改善皮肤弹性的植物活性弹力因子aef
CN104958204A (zh) * 2015-06-18 2015-10-07 湖南炎帝生物工程有限公司 一种含有葛仙米提取物的洗发液及其制备方法
CN110225975A (zh) 2016-08-23 2019-09-10 阿库斯股份有限公司 用于治疗人受试者中非年龄相关的听力损害的组合物和方法
JP2019535829A (ja) 2016-11-21 2019-12-12 エイリオン セラピューティクス， インコーポレイテッド 大型薬剤の経皮送達
EP4114958A1 (de) 2020-02-21 2023-01-11 Akouos, Inc. Zusammensetzungen und verfahren zur behandlung von nicht altersbedingten hörschäden bei einer person

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU41412B (en) * 1978-08-15 1987-04-30 Gist Brocades Nv Process for obtaining 17 beta-hydroxy -3-dxo-17 alpha-pregn-4-en-21-carboxylic acid
LU83173A1 (fr) * 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
US6093706A (en) * 1992-03-04 2000-07-25 Bioresponse, L.L.C. Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
JPH11501315A (ja) * 1995-03-06 1999-02-02 イーストマン ケミカル カンパニー 化粧品成分用の無水系運搬担体
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
DE19615577A1 (de) * 1996-04-19 1997-10-23 Beiersdorf Ag Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
FR2749758B1 (fr) * 1996-06-12 1998-08-07 Oenobiol Sa Lab Composition a activite bronzante et photoprotectrice et ses applications esthetiques
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5855897A (en) * 1996-09-13 1999-01-05 E-L Management Corp. Topical composition and method for enhancing lipid barrier synthesis
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
JP2002515898A (ja) * 1997-02-25 2002-05-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ヒトの皮膚での経時老化を防止および治療するための方法および組成物
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
ES2384552T3 (es) * 1997-09-05 2012-07-06 The Procter & Gamble Company Productos de limpieza y acondicionado para la piel o el pelo con mejor deposición de los ingredientes acondicionadores
EP0908183A1 (de) * 1997-10-08 1999-04-14 Institute For Advanced Skin Research Inc. Dehydroepiandrosterone oder ihre Derivate zur Erhöhung des Hyaluronische Saüre-Gehalts der Haut
US6048846A (en) * 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
US6232530B1 (en) * 1998-11-30 2001-05-15 University Of Nevada Marigold DNA encoding beta-cyclase
FR2799370B1 (fr) * 1999-10-07 2005-08-19 Oreal Utilisation du lycopene dans des compositions destinees a traiter les signes cutanes du vieillissement
FR2799759B1 (fr) * 1999-10-14 2001-11-30 Oreal Composition, notamment cosmetique, comprenant une sapogenine

Also Published As

Publication number Publication date
EP1303251A1 (de) 2003-04-23
WO2002005775A1 (fr) 2002-01-24
ES2230329T3 (es) 2005-05-01
DE60106265D1 (de) 2004-11-11
US20040005370A1 (en) 2004-01-08
EP1303251B1 (de) 2004-10-06
FR2811561A1 (fr) 2002-01-18
FR2811561B1 (fr) 2003-03-21
DE60106265T2 (de) 2005-10-20
AU2001266133A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
ATE278384T1 (de) Zusammensetzung, insbensodere für kosmetika, enthaltend dhea und/oder einen chemische oder biologische vorläufer davon und einen metalloproteinase inhibitor
GB2396297B (en) A cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses.
CY1111003T1 (el) Συνθεσεις για τη θεραπεια ατοπικης δερματιτιδας, αλλεργικων καταστασεων του δερματος και ακμης
DE60137329D1 (de) Zusammensetzungen zur behandlung von diabetes die einen dp iv-inhibitoren und einen andere antidiabetikum enthalten
DE60142590D1 (de) Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen
ATE530179T1 (de) Verwendung von kreatin und/oder kreatinderivaten in dermatologischen zubereitungen
ATE196844T1 (de) Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
ATE555380T1 (de) Verfahren zur änderung des schicksals von zellen
NO973900L (no) Nitrogenoksyd syntase inhibitor
EA200970154A1 (ru) Косметические или дерматологические препараты, содержащие n-ацетилцистеин
ATE333263T1 (de) Echinacea-extrakt als antireizendes und alterungsschutzmittel für kosmetika
DE60312211D1 (de) Haarbehandlungsmittel
ATE464038T1 (de) Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
MXPA05012753A (es) Composiciones cosmeticas estables que comprenden un agente autobronceador.
FR2848116B1 (fr) Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
FR2834459B1 (fr) Agent microbicide et composition de traitement cosmetique le contenant
EP1430933A3 (de) Kosmetische und pharmazeutische Zusammensetzungen enthaltend Steroidsulfatase-Inhibitoren und deren Verwendung zur Verminderung von Haarausfall
DE602004023762D1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren
ATE421870T1 (de) 2-phenylethylbenzoat in kosmetischen öl-in-wasser-uv-lichtschutzemulsionen
BRPI0514356A (pt) composição de cuidado com o cabelo, método de tratar cabelo, e, uso de uma macromolécula dendrìtica hidrofobicamente funcionalizada
FR2825273B1 (fr) Composition pour le traitement des signes cutanes du vieillissement
DE60101559D1 (de) Benutzung von comt-inhibitoren als analgetika
DE60135364D1 (de) Verwendung von beta-carotin und lycopin zur behandlung des hautalterns durch inhibierung der auswirkung der metalloproteinase des typs 1 der extrazellularen matrix
ATE269700T1 (de) Verwendung von docetaxel für die behandlung von hepatozelluläre krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties